Jungang Vaccine Reports Operating Profit of 2.042 Billion KRW in Q2, Up 504.1% Year-on-Year

[Asia Economy Reporter Oh Ju-yeon] Jungang Vaccine announced on the 22nd that its operating profit for the second quarter of this year increased by 504.1% compared to the same period last year, reaching 2.042 billion KRW. Sales rose by 22.8% to 10.422 billion KRW, and net profit turned positive to 2.091 billion KRW.